Amazon To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Wednesday

BenzingaDec 18 10:20 ET

4D Molecular Therapeutics Analyst Ratings

BenzingaDec 18 07:49 ET · Ratings

BofA Securities Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Cuts Target Price to $46

Moomoo NewsDec 18 07:31 ET · Ratings

Express News | 4D Molecular Therapeutics Inc : BofA Global Research Cuts Price Objective to $46 From $79

ReutersDec 18 07:16 ET

Express News | 4Dmt Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in Iovs

ReutersDec 16 08:00 ET

We Think 4D Molecular Therapeutics (NASDAQ:FDMT) Can Afford To Drive Business Growth

Simply Wall StNov 27 06:17 ET